LPA and myocardial infarction: Authors have also described Lp(a) as an acute phase reactant with increased levels in acute illnesses such as myocardial infarction, inflammatory bowel disease, gallbladder fistula, sepsis, etc. Thus, it is mandatory to consider these clinical features in Lp(a) assay results evaluation [2,7].